HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Esophagectomy as therapeutic principle for squamous cell esophageal cancer].

Abstract
The fatalistic approach towards surgical therapy of esophageal squamous cell cancer has been replaced in recent years by a more differentiated view. This was triggered by the establishment of individualized therapeutic modalities based on tumor stage, tumor location, general patient status, and comorbidity. Despite advances in nonsurgical therapy of squamous cell esophageal cancer, esophagectomy remains the central therapeutic modality. Primary subtotal en-bloc esophagectomy with lymphadenectomy is the only curative option with a high likelihood of success for resectable tumors (uT1-3 categories) located below the level of the tracheal bifurcation and for early more proximal tumors. In patients with locally advanced tumors at or above the level of the tracheal bifurcation, surgical resection can still cure those who respond to neoadjuvant radiochemotherapy. Preoperative "conditioning" of risk patients, surgical safety strategies in risk situations, and standardization of both the operative procedure and the perioperative management have resulted in a marked reduction of the previously substantial postoperative mortality to below 3% in experienced centers. In our own experience of 900 esophagectomies for squamous cell esophageal cancer, the 5-year survival rate rose from about 20% to more than 50% in the last two decades. Esophagectomy thus has become a safe operation and remains the only therapeutic option offering cure for a substantial proportion of patients with squamous cell cancer of the esophagus.
AuthorsJ R Siewert, M Feith, H J Stein
JournalDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen (Chirurg) Vol. 76 Issue 11 Pg. 1033-43 (Nov 2005) ISSN: 0009-4722 [Print] Germany
Vernacular TitleOsophagektomie als chirurgisches Therapieprinzip beim Plattenepithelkarzinom des Osophagus.
PMID16228234 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Adenocarcinoma (mortality, pathology, radiotherapy, surgery)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy, surgery)
  • Esophageal Neoplasms (mortality, pathology, radiotherapy, surgery)
  • Esophagectomy
  • Esophagoplasty (methods)
  • Esophagus (pathology)
  • Humans
  • Lymph Node Excision
  • Neoadjuvant Therapy
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: